Prevalence of treatment resistance and clozapine use in early intervention services
BackgroundTreatment resistance causes significant burden in psychosis. Clozapine is the only evidence-based pharmacologic intervention available for people with treatment-resistant schizophrenia; current guidelines recommend commencement after two unsuccessful trials of standard antipsychotics.AimsT...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2020-09-01
|
Series: | BJPsych Open |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2056472420000897/type/journal_article |